Nimbus Synergies Inc.
VC Fund
Vancouver, Canada
Nimbus Synergies Inc. is a VC fund in Vancouver focused on Health Care and Software. Nimbus Synergies leads early-stage financings in innovative and complementary digital health companies in British Columbia. By bringing these companies together to share resources, industry specific knowledge, and relationships, Nimbus is accelerating their growth and increasing their likelihood of success. Nimbus is significantly impacting theburgeoning yet underserved digital health sector through its leadership as investor, partner, and mentor. It is one of the most exciting additions to the province’s technology industry and the newest member of Discovery Parks’ group of companies. By investing Discovery Parks’ assets in startups focused on the intersection between life sciences and technology, Nimbus aims to improve health through BC-led innovation.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 63%
Last updated:
For AI agents: llms.txt
Industries Nimbus Synergies Inc. invests in
Stages Nimbus Synergies Inc. invests in
Countries Nimbus Synergies Inc. invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Round size
- Seed
- $970k–$5.5M
- Series A
- $5.9M–$7.3M
Investment Focus
Industry
- Health Care 9 (47%)
- Software 3 (16%)
- Medical Device 3 (16%)
- Medical 2 (11%)
- Wellness 2 (11%)
Stage
- Seed 7 (37%)
- Series A 4 (21%)
- Funding Round 3 (16%)
- Convertible Note 1 (5%)
Country
- Canada 12 (63%)
- United States 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Darrell Elliott
Director and Investment Committee Chair
|
Director and Investment Committee Chair | Total investments: 0 | Find email | |
Jason Robertson
Founder, VP, Investments
|
Founder, VP, Investments | Total investments: 3 | Find email | |
|
Paul Geyer
C.E.O
|
C.E.O | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
A&K Robotics
|
A&K Robotics was founded on a shared belief that robotic technologies has the potential to drastically improve Their world and quality of life. They see the future with unique eyes, pushing the boundaries of robotics and seeking real-life applications of new technologies. | $5.9M / Series A / Apr 21, 2026 | |
Variational AI
|
Variational AI uses state-of-the-art machine learning in a data-efficient method to rapidly generate novel and diverse compounds that are optimized for multiple properties to avoid the most common causes of drug attrition and increase clinical probability of success. Variational AI works with leading biopharmaceutical partners and is developing itsown internal pipeline. | $5.5M / Seed / Feb 20, 2025 | |
EmergConnect
|
Emergconnect is creating the first ever digital 'front door' for patients seeking same day care. | $1.2M / Seed / Dec 20, 2024 | |
VitaminLab
|
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry. | Series A / May 08, 2023 | |
|
VitaminLab
|
VitaminLab takes your health history, our nutrient testing or health data, and uses our matching algorithm to create an all-in-one personalized supplement that impacts your health. The company, run by a team of pharmacists and health care professionals, was founded to change the status quo of the supplement industry. | Series A / May 08, 2023 | |
Arbutus Medical
|
Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $2.3M / Seed / Feb 13, 2023 | |
Sonic Incytes
|
Sonic Incytes is a medical device start-up company developing quantitative ultrasound for point-of-care diagnostic and procedure guidance. our mission to enable routine assessment and management of liver health, with diagnostic accuracy you can count on. | $7.3M / Series A / Dec 07, 2021 | |
LifeBooster
|
LifeBooster is pioneering the future of enterprise health and safety. We operate at the intersection of risk analytics, wearable IoT and Insurtech. Our team has developed a breakthrough connected worker platform, Senz, for predicting and modeling risks and exposures for an entire workforce to prevent injuries, illness, and death in the workplace.Senz digitizes, automates and scales proven standards professionals rely on for accurate risk assessment and injury prevention. LifeBooster has had notable successes reducing risks across the industrial economy by up to 80%. Partnering with local and global leaders in enterprise health and safety, workers' compensation, and risk management, LifeBooster has quickly become one of the world's leading connected worker solutions, ensuring every worker gets home safe every day. | Series A / Aug 24, 2021 | |
|
Arbutus Medical
|
Every hospital in the world is faced with a major challenge - the rising cost of heathcare - we want to do something about it. Arbutus Medical’s purpose is to develop a portfolio of “frugal innovation” devices that save costs for hospitals and improve access to orthopedic surgery for 5 million patients by 2030. Arbutus Medical's flagshipproduct is a radically affordable orthopaedic power tool system that is used in North American Trauma Centers, veterinary hospitals, military deployments, NGO missions, and hospitals in over 30 low- and middle-income countries worldwide. | $1.2M / Seed / Jul 29, 2020 | |
|
LifeBooster
|
LifeBooster is pioneering the future of enterprise health and safety. We operate at the intersection of risk analytics, wearable IoT and Insurtech. Our team has developed a breakthrough connected worker platform, Senz, for predicting and modeling risks and exposures for an entire workforce to prevent injuries, illness, and death in the workplace.Senz digitizes, automates and scales proven standards professionals rely on for accurate risk assessment and injury prevention. LifeBooster has had notable successes reducing risks across the industrial economy by up to 80%. Partnering with local and global leaders in enterprise health and safety, workers' compensation, and risk management, LifeBooster has quickly become one of the world's leading connected worker solutions, ensuring every worker gets home safe every day. | $1.6M / Seed / Mar 15, 2020 | |
| See all 19 investments → | |||
Co-Investors
Threshold Impact
3 deals together
WUTIF
3 deals together
BC Tech Association
2 deals together
DSM Venturing
2 deals together
entrepreneurship@UBC
2 deals together
MAVAN Capital Partners
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Nimbus Synergies Inc. invest in?
Nimbus Synergies Inc. invests primarily in Health Care, Software and Medical Device startups, most often at Seed and Series A stage. Most of the 19 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Nimbus Synergies Inc.'s check size?
Nimbus Synergies Inc. typically joins rounds of $970k–$5.5M at Seed and $5.9M–$7.3M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nimbus Synergies Inc. participates in.
How do I contact Nimbus Synergies Inc.?
Public channels for Nimbus Synergies Inc. include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Nimbus Synergies Inc.?
The team at Nimbus Synergies Inc. includes Darrell Elliott (Director and Investment Committee Chair), Jason Robertson (Founder, VP, Investments) and Paul Geyer (C.E.O). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
